Partnering with life science innovators to achieve commercialization goals

Developing trailblazing therapies is filled with unknowns. Solvias helps smooth your journey—from concept to clinic to commercialization—with CMC analytical services as pioneering as your product. Pharma and biotech innovators worldwide turn to us for creative solutions powered by scientific expertise and a strong focus on customer success.


Why choose Solvias as your CRO partner?

Scientific Sophistication

Solvias has an exceptional level of scientific, regulatory, and project management knowledge gained through years of experience helping customers commercialize safe products. Our talented experts have the know-how, creativity and tenacity to solve even the most complex analytical and process challenges. Their ability to develop innovative solutions in critical early stages helps ensure success as you transition to commercial scale.

Shared Commitment

With Solvias, you have a team of top-tier analytical experts at your side throughout your development journey, personally invested in your success. We share your scientific and business goals, and seek to build long-term partnerships. Our commitment to collaboration extends to sharing the risks inherent in developing trailblazing therapies.

Comprehensive Solutions

CMC analytical testing is our core focus. Within this specialized field, we offer a comprehensive solution—from raw materials to drug products to final release testing, plus API product development and manufacturing for small molecules. With Solvias, you have a single, trusted analytical partner for your entire development journey.

Quality Obsession

We understand our work is critical to your ability to develop innovative therapies while protecting patient safety. We focus on the details to deliver the highest quality results, delivered in a form that is regulatory-ready. Our proven processes and continuous investments in cutting-edge technologies enable us to rapidly deliver high-quality, cGMP-compliant services at scale.

175 +
PhD-level scientists
800 +
team members in Europe & U.S.
700 +
customers worldwide
of the top 20 pharma companies choose Solvias
decorative roadmap graphic

A history of growth and innovation

With deep pharmaceutical roots, Solvias is founded after being part of Novartis


Solvias headquarters are established in Kaiseraugst, Switzerland


Solvias acquires Confarma to expand services to pharmaceutical industry


Solvias partners with two healthcare investment firms to advance expansion


Solvias acquires Chemic to establish U.S. laboratory presence


Archie Cullen is appointed Chief Executive Officer


Solvias acquires Cergentis to bolster biologics and CGT capabilities


Solvias rolls out comprehensive LIMS


Contact us for a complimentary consultation